Neogen Corporation Class Action Alert
Investors in Neogen Corporation have received a timely reminder regarding an important deadline associated with a securities class action lawsuit. Those who have incurred losses exceeding $100,000 during the designated period are eligible to take part in this legal action, making it crucial for them to stay informed about their rights and the next steps involved.
Details of the Securities Class Action
The class action lawsuit against Neogen Corporation centers on allegations that the company, along with certain executives, failed to disclose crucial information that is material to investors during the class period. Specifically, shareholders who purchased Neogen shares from January 5, 2023, through June 3, 2025, are directly impacted. The claim is currently filed in the United States District Court for the Western District of Michigan.
What You Need to Know
Investors aiming to participate must file their applications for lead plaintiff status by the upcoming deadline. This is a protective measure intended for shareholders to ensure they can advocate for their interests in the class action case effectively. The timeline set for this class action is crucial and demands immediate attention from those who might qualify.
Recent Developments Impacting Neogen's Share Value
Recent financial disclosures by Neogen have raised significant concerns among investors. On one notable occasion, the company reported a 3.4% decline in quarterly revenue, amounting to $221 million. This downturn was largely attributed to unforeseen integration issues, leading to a downward revision of their financial guidance for FY25. Included in the announcement was the expected capital expenditure of $100 million due to lower adjusted EBITDA.
Market Reaction and Stock Performance
The reaction from the market was swift—as soon as this information was made public, Neogen's stock experienced steep declines. For instance, on April 9, 2025, the price of Neogen shares fell by 28%, closing at $5.02 per share amid heightened trading activity. Furthermore, a subsequent announcement regarding expected EBITDA margins also contributed to ongoing declines, as shares fell further to $4.96 shortly thereafter.
Legal Options for Affected Investors
For those affected by the declines in share value, seeking legal recourse through this class action could prove beneficial. Law firms, such as Kahn Swick & Foti, LLC, are available to offer consultations for investors wanting to explore their options for participating in the class action lawsuit and potentially recovering losses incurred during the troubled financial period.
Next Steps for Neogen Investors
Investors are encouraged to act promptly and gather all necessary documentation regarding their shares in Neogen. By submitting their lead plaintiff applications ahead of the deadline, they can ensure their voices are heard in this crucial legal battle. For further support, it is advisable to reach out to ClaimsFiler, a dedicated resource helping retail investors navigate the complexities of class action settlements.
Frequently Asked Questions
What is the lead plaintiff deadline for the class action against Neogen?
The lead plaintiff deadline for the class action lawsuit against Neogen Corporation is set for September 16, 2025.
How can I determine if I'm eligible for the class action?
If you purchased shares of Neogen between January 5, 2023, and June 3, 2025, you may be eligible to participate in the class action.
What factors led to the decline in Neogen's stock value?
The decline in Neogen’s stock value can be attributed to integration issues, lowered revenue forecasts, and diminished EBITDA margin expectations.
What should I do if I incurred losses from Neogen shares?
If you incurred losses, consider consulting with a law firm experienced in securities class actions to discuss your legal options.
Who can I contact for more information about my rights?
Investors seeking information on their rights can contact ClaimsFiler at toll-free (844) 367-9658 or visit their website for further assistance.
